Human Immunodeficiency Virus Type 1 RNA Genital Tract Shedding After Cryotherapy for Cervical Intraepithelial Neoplasia in Western Kenya

被引：0

作者：

Orang'o, Elkanah Omenge ^{[1
]}

Bocage, Anne E. ^{[2
]}

Liu, Tao D. ^{[3
]}

Itsura, Peter M. ^{[1
]}

Tonui, Philip K. ^{[1
]}

Muthoka, Kapten ^{[4
]}

Stephen, Kiptoo ^{[1
]}

Caliendo, Angela M. ^{[5
]}

Sam, Soya S. ^{[5
,6
]}

Cu-Uvin, Susan ^{[5
]}

机构：

[1] Moi Univ, Dept Reprod Hlth, Eldoret, Kenya

[2] Brown Univ, Warron Alpert Med Sch, 222 Richmond St,Box G-M117, Providence, RI 02912 USA

[3] Brown Univ, Dept Biostat, Providence, RI USA

[4] Acad Model Providing Access Healthcare Partnershi, Eldoret, Kenya

[5] Brown Univ, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02912 USA

[6] Miriam Hosp, Div Infect Dis, Providence, RI 02906 USA

来源：

OPEN FORUM INFECTIOUS DISEASES | 2023年 / 10卷 / 01期

基金：

美国国家卫生研究院;

关键词：

cervical cancer; cervical cancer treatment; cryotherapy; HIV; HIV genital tract viral load; Kenya; PLASMA; HIV; WOMEN;

D O I：

10.1093/ofid/ofac662

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This prospective study of 39 women living with human immunodeficiency virus (HIV) on antiretroviral therapy in Western Kenya aimed to quantify genital tract HIV-1 RNA (GT-HIV RNA) shedding before and after cryotherapy for cervical intraepithelial neoplasia. Most GT-HIV RNA shedding was detected precryotherapy, suggesting that cryotherapy was not the primary cause of shedding.

引用

页数：5

共 50 条

[31] PSYCHONEUROIMMUNOLOGICAL ASPECTS OF DISEASE PROGRESSION AMONG WOMEN WITH HUMAN PAPILLOMAVIRUS-ASSOCIATED CERVICAL DYSPLASIA AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COINFECTION
GOODKIN, K
ANTONI, MH
HELDER, L
SEVIN, B
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 1993, 23 (02) : 119 - 148
[32] Genital Human Immunodeficiency Virus-1 RNA and DNA Shedding in Virologically Suppressed Individuals Switching From Triple- to Dual- or Monotherapy: Pooled Results From 2 Randomized, Controlled Trials
Hocqueloux, Laurent
Gubavu, Camelia
Prazuck, Thierry
De Dieuleveult, Barbara
Guinard, Jerome
Seve, Aymeric
Mille, Catherine
Gardiennet, Elise
Lopez, Pauline
Rouzioux, Christine
Lefeuvre, Sandrine
Avettand-Fenoel, Veronique
CLINICAL INFECTIOUS DISEASES, 2020, 70 (09) : 1973 - 1979
[33] Comparisons of Human Immunodeficiency Virus Type 1 Envelope Variants in Blood and Genital Fluids near the Time of Male-to-Female Transmission
Williams-Wietzikoski, Corey A.
Campbell, Mary S.
Payant, Rachel
Lam, Airin
Zhao, Hong
Huang, Hannah
Wald, Anna
Stevens, Wendy
Gray, Glenda
Farquhar, Carey
Rees, Helen
Celum, Connie
Mullins, James I.
Lingappa, Jairam R.
Frenkel, Lisa M.
Celum, Connie
Wald, Anna
Lingappa, Jairam R.
Baeten, Jared M.
Campbell, Mary S.
Corey, Lawrence
Coombs, Robert W.
Hughes, James P.
Magaret, Amalia
McElrath, M. Juliana
Morrow, Rhoda
Mullins, James I.
Coetzee, David
Fife, Kenneth
Were, Edwin
Essex, Max
Makhema, Joseph
Katabira, Elly
Ronald, Allan
Allen, Susan
Kayitenkore, Kayitesi
Karita, Etienne
Bukusi, Elizabeth
Cohen, Craig
Allen, Susan
Kanweka, William
Allen, Susan
Vwalika, Bellington
Kapiga, Saidi
Manongi, Rachel
Farquhar, Carey
John-Stewart, Grace
Kiarie, James
Allen, Susan
Inambao, Mubiana
JOURNAL OF VIROLOGY, 2019, 93 (13)
[34] Formation of RNA Granule-Derived Capsid Assembly Intermediates Appears To Be Conserved between Human Immunodeficiency Virus Type 1 and the Nonprimate Lentivirus Feline Immunodeficiency Virus
Reed, Jonathan C.
Westergreen, Nick
Barajas, Brook C.
Ressler, Dylan T. B.
Phuong, Daryl J.
Swain, John V.
Lingappa, Vishwanath R.
Lingappa, Jaisri R.
JOURNAL OF VIROLOGY, 2018, 92 (09)
[35] Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya
Papas, Rebecca K.
Sidle, John E.
Gakinya, Benson N.
Baliddawa, Joyce B.
Martino, Steve
Mwaniki, Michael M.
Songole, Rogers
Omolo, Otieno E.
Kamanda, Allan M.
Ayuku, David O.
Ojwang, Claris
Owino-Ong'or, Willis D.
Harrington, Magdalena
Bryant, Kendall J.
Carroll, Kathleen M.
Justice, Amy C.
Hogan, Joseph W.
Maisto, Stephen A.
ADDICTION, 2011, 106 (12) : 2156 - 2166
[36] A SIMPLIFIED METHOD FOR QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA IN PLASMA - CLINICAL CORRELATES
STRICKER, RB
ZHU, YS
ELSWOOD, BF
RESEARCH IN VIROLOGY, 1995, 146 (02): : 151 - 158
[37] Human Immunodeficiency Virus Type 1 RNA Levels in Rectal and Seminal Compartments After Switching to Long-Acting Cabotegravir Plus Rilpivirine: A Longitudinal Study
Masia, Mar
Fernandez-Gonzalez, Marta
Agullo, Vanesa
Mascarell, Paula
Padilla, Sergio
Garcia-Abellan, Javier
Gutierrez, Felix
CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E748 - E751
[38] Incidence of cervical intraepithelial neoplasia in women infected with human immunodeficiency virus (HIV) with no evidence of disease at baseline: Results of a prospective cohort study with up to 6.4 years of follow-up from India
Joshi, Smita
Muwonge, Richard
Kulkarni, Vinay
Deodhar, Kedar
Mandolkar, Mahesh
Lucas, Eric
Sankaranarayanan, Rengaswamy
INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (05) : 1082 - 1091
[39] Improved conditions for extraction and amplification of human immunodeficiency virus type 1 RNA from plasma samples with low viral load
Villahermosa, ML
Thomson, M
de Parga, EV
Cuevas, MT
Contreras, G
Pérez-Alvarez, L
Delgado, E
Manjón, N
Medrano, L
Nájera, R
JOURNAL OF HUMAN VIROLOGY, 2000, 3 (01) : 27 - 34
[40] Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex
Keen, NJ
Churcher, MJ
Karn, J
EMBO JOURNAL, 1997, 16 (17) : 5260 - 5272

← 1 2 3 4 5 →